Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Operating Expenses: 2019-2025

Historic Other Operating Expenses for Whitehawk Therapeutics (WHWK) over the last 3 years, with Sep 2025 value amounting to -$177,000.

  • Whitehawk Therapeutics' Other Operating Expenses fell 122.01% to -$177,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $88.9 million, marking a year-over-year increase of 2711.14%. This contributed to the annual value of $3.0 million for FY2024, which is 7.65% up from last year.
  • As of Q3 2025, Whitehawk Therapeutics' Other Operating Expenses stood at -$177,000, which was down 100.20% from $87.4 million recorded in Q1 2025.
  • In the past 5 years, Whitehawk Therapeutics' Other Operating Expenses registered a high of $87.4 million during Q1 2025, and its lowest value of -$177,000 during Q3 2025.
  • Over the past 3 years, Whitehawk Therapeutics' median Other Operating Expenses value was $737,500 (recorded in 2023), while the average stood at $9.3 million.
  • Data for Whitehawk Therapeutics' Other Operating Expenses shows a peak YoY increase of 13,311.50% (in 2025) and a maximum YoY decrease of 122.01% (in 2025) over the last 5 years.
  • Whitehawk Therapeutics' Other Operating Expenses (Quarterly) stood at $74.2 million in 2021, then tumbled by 99.20% to $222,000 in 2022, then soared by 317.57% to $927,000 in 2023, then dropped by 14.78% to $790,000 in 2024, then plummeted by 122.01% to -$177,000 in 2025.
  • Its Other Operating Expenses was -$177,000 in Q3 2025, compared to $87.4 million in Q1 2025 and $790,000 in Q4 2024.